NO20002190L - 2-halo-6-O-substituerte ketolidderivater - Google Patents

2-halo-6-O-substituerte ketolidderivater

Info

Publication number
NO20002190L
NO20002190L NO20002190A NO20002190A NO20002190L NO 20002190 L NO20002190 L NO 20002190L NO 20002190 A NO20002190 A NO 20002190A NO 20002190 A NO20002190 A NO 20002190A NO 20002190 L NO20002190 L NO 20002190L
Authority
NO
Norway
Prior art keywords
halo
ketolide derivatives
substituted ketolide
substituted
derivatives
Prior art date
Application number
NO20002190A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002190D0 (no
Inventor
Ly Tam Phan
Yat Sun Or
Daniel T Chu
Jacob J Plattner
Yan Chen
Richard F Clark
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20002190D0 publication Critical patent/NO20002190D0/no
Publication of NO20002190L publication Critical patent/NO20002190L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO20002190A 1997-10-29 2000-04-27 2-halo-6-O-substituerte ketolidderivater NO20002190L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US15423998A 1998-09-16 1998-09-16
PCT/US1998/022989 WO1999021871A1 (en) 1997-10-29 1998-10-29 2-halo-6-o-substituted ketolide derivatives

Publications (2)

Publication Number Publication Date
NO20002190D0 NO20002190D0 (no) 2000-04-27
NO20002190L true NO20002190L (no) 2000-06-29

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002190A NO20002190L (no) 1997-10-29 2000-04-27 2-halo-6-O-substituerte ketolidderivater

Country Status (25)

Country Link
EP (1) EP1027362B1 (de)
JP (1) JP2001521039A (de)
KR (1) KR100536420B1 (de)
CN (1) CN1240707C (de)
AR (1) AR015994A1 (de)
AT (1) ATE298760T1 (de)
AU (1) AU751448B2 (de)
BG (1) BG64707B1 (de)
BR (1) BR9813319A (de)
CA (1) CA2307788C (de)
CO (1) CO4990960A1 (de)
CZ (1) CZ300063B6 (de)
DE (1) DE69830739T2 (de)
DK (1) DK1027362T3 (de)
ES (1) ES2244094T3 (de)
HK (1) HK1031383A1 (de)
HU (1) HUP0004282A3 (de)
IL (1) IL135519A0 (de)
NO (1) NO20002190L (de)
NZ (1) NZ503822A (de)
PL (1) PL191453B1 (de)
PT (1) PT1027362E (de)
SK (1) SK286397B6 (de)
TR (1) TR200001142T2 (de)
WO (1) WO1999021871A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
KR20020007374A (ko) * 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
WO2001040241A2 (en) * 1999-12-02 2001-06-07 Abbott Laboratories 6-o-alkyl-2-nor-2-substituted ketolide derivatives
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2001261694A (ja) 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
PT1167376E (pt) 2000-06-30 2004-09-30 Pfizer Prod Inc Antibioticos macrolidos
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
JP2005503416A (ja) 2001-09-17 2005-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 6−o−カルバメート−11,12−ラクト−ケトライド抗菌剤
EP1453847A1 (de) 2001-12-05 2004-09-08 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivate von erythromycin verwendbar als antibakterielles mittels
JP2005522453A (ja) * 2002-02-13 2005-07-28 アボット・ラボラトリーズ マクロライド抗菌化合物
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
MXPA04010556A (es) * 2002-04-25 2005-02-17 Abbott Lab Antibacterianos oxalida.
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. 2-フルオロ-6-o-置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2−フルオロ−6−o−置換ケトライド誘導体
KR101566053B1 (ko) * 2009-05-27 2015-11-04 욱크하르트 리미티드 항균 활성을 갖는 케톨라이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
KR0166996B1 (ko) * 1992-04-22 1999-01-15 우에하라 아키라 5-o-데소사미닐에리쓰로노라이드a 유도체
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
TR200001142T2 (tr) 2000-09-21
KR20010015793A (ko) 2001-02-26
SK286397B6 (sk) 2008-09-05
CZ20001525A3 (cs) 2000-10-11
HUP0004282A3 (en) 2001-10-29
CZ300063B6 (cs) 2009-01-21
ATE298760T1 (de) 2005-07-15
EP1027362A1 (de) 2000-08-16
DK1027362T3 (da) 2005-10-31
NZ503822A (en) 2002-12-20
ES2244094T3 (es) 2005-12-01
JP2001521039A (ja) 2001-11-06
AU751448B2 (en) 2002-08-15
NO20002190D0 (no) 2000-04-27
SK6332000A3 (en) 2000-09-12
KR100536420B1 (ko) 2005-12-16
AU1288199A (en) 1999-05-17
BR9813319A (pt) 2000-08-22
DE69830739T2 (de) 2006-04-20
AR015994A1 (es) 2001-05-30
PT1027362E (pt) 2005-08-31
CA2307788C (en) 2008-05-20
WO1999021871A1 (en) 1999-05-06
EP1027362B1 (de) 2005-06-29
CA2307788A1 (en) 1999-05-06
DE69830739D1 (de) 2005-08-04
PL340290A1 (en) 2001-01-29
CN1240707C (zh) 2006-02-08
HUP0004282A2 (hu) 2001-04-28
PL191453B1 (pl) 2006-05-31
BG104434A (en) 2001-01-31
BG64707B1 (bg) 2005-12-30
CO4990960A1 (es) 2000-12-26
IL135519A0 (en) 2001-05-20
HK1031383A1 (en) 2001-06-15
CN1283199A (zh) 2001-02-07

Similar Documents

Publication Publication Date Title
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
PT915088E (pt) Derivados de d-prolina
DK0930302T3 (da) Benzosulfonderivater
ATE259810T1 (de) Phenyl-xanthinderivate
ATE377018T1 (de) Erythromycinderivate
NO20000231D0 (no) Dolastatin-15-derivater
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
ATE255099T1 (de) Substituierte chromanderivate
ATE239030T1 (de) Kohlenhydrat-derivate
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de) Chromanderivate
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
DK1060183T3 (da) 5-deoxycytidinderivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application